• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Strategic Analysis of the European Specialty Pharma Market Product Image

Strategic Analysis of the European Specialty Pharma Market

  • Published: March 2009
  • Region: Europe
  • 58 Pages
  • Frost & Sullivan

This Frost & Sullivan research service titled Strategic Analysis of the European Specialty Pharma Market provides the market overview, market engineering research, competitor analysis and therapeutic area-wise opportunity analysis. This research service includes an examination of how the healthcare delivery models differ from one country to another, the regulatory framework for healthcare companies as well as the regulatory barriers to entry, and the best route to market for both global companies and smaller market participants alike. The following market segments have been covered in this research: cardiovascular diseases, central nervous system disorders, ophthalmology, women’s health, and urology.

This research service provides a strategic analysis of the European specialty pharma market and includes an introduction, market overview, market engineering research, competitor analysis, global therapeutic-area wise opportunity analysis, and strategic recommendations.

Market Overview

Innovative Business Models and Focus on Niche Therapeutic Areas Bolster the European Specialty Pharmaceutical Markets

Confronted by a vast array of challenges such as READ MORE >

1 EXECUTIVE SUMMARY

2 GLOSSARY OF TERMS AND RESEARCH METHODOLOGY

- Glossary of Terms
- - List of Terms

- Research Methodology
- - Methodology

3 THE SPECIALTY PHARMACEUTICALS MARKET

- Introduction
- - Definitions
- - Existing and Emerging Business Models
- - Market Overview

- Market Engineering Research
- - Industry Challenges
- - Market Drivers
- - Market Restraints
- - Competitive Structure

4 COMPETITOR ANALYSIS

- Key Competitors
- - Market Share Analysis

5 GLOBAL THERAPEUTIC AREA-WISE OPPORTUNITY ANALYSIS

- Analysis by Segment
- - Cardiovascular Diseases
- - Central Nervous System Disorders
- - Ophthalmology
- - Women's Health
- - Urology
- - Dermatology

6 STRATEGIC RECOMMENDATIONS

- Recommendations
- - Strategies for Specialty Pharma Companies

7 DATABASE OF KEY INDUSTRY PARTICIPANTS

- DKIP
- - Key Market Participants

8 DECISION SUPPORT DATABASES

- DSDs
- - Prevalence of Parkinson's Disease
- - Prevalence of Glaucoma
- - Prevalence of Urinary Incontinence
- - Prevalence of Hypertension
- - Prevalence of Alzheimer's Disease

- List of Figures
- - Specialty Pharma Market: Impact of Top Two Industry Challenges (Europe), 2009-2015
- - Specialty Pharma Market: Market Drivers Ranked in Order of Impact (Europe), 2009-2015
- - Specialty Pharma Market: Market Restraints Ranked in Order of Impact (Europe), 2009-2015
- - Specialty Pharma Market: Competitive Structure (Europe), 2008
- - Decision Support Database: Prevalence of Parkinson's Disease in '000 (World), 1999-2006
- - Decision Support Database: Prevalence of Glaucoma in '000 (World), 1999-2006
- - Decision Support Database: Prevalence of Urinary Incontinence in Million (World), 1999-2006
- - Decision Support Database: Prevalence of Hypertension in Million (World), 1999-2006
- - Decision Support Database: Prevalence of Alzheimer's disease in '000 (World), 1999-2006

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos